SCHEMBL4737286

SCHEMBL4737286

O=C(CBr)c1c(O)cccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA7 P43166 3/20 0.43
CA9 Q16790 3/20 0.43
CA14 Q9ULX7 3/20 0.43
PTPN1 P18031 4/20 0.42
THRB P10828 1/20 0.42
GSK3B P49841 1/20 0.41
SPR P35270 1/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278384 0.88 CES2 (0.56) CES2CES1MEN1KMT2APTPN1
SCHEMBL31298356 0.81 CES2 (0.48) CES2CES1MEN1KMT2APTPN1
SCHEMBL12780415 0.81 CA9 (0.48) CES2CES1MEN1KMT2ACA12
SCHEMBL30016040 0.79 KMT2A (0.56) CES2CES1MEN1KMT2AMAPT
SCHEMBL3467976 0.79 KMT2A (0.56) CES2CES1MEN1KMT2AMAPT
SCHEMBL27203878 0.78 KMT2A (0.51) CES2CES1MEN1KMT2ACA12
SCHEMBL11581348 0.78 NR4A2 (0.46) CES2CES1MEN1KMT2ACA12
SCHEMBL12533486 0.77 CA12 (0.48) MEN1KMT2ACA12CA1CA2
SCHEMBL2096065 0.77 CES2 (0.44) CES2CES1MEN1KMT2APTPN1
SCHEMBL617480 0.75 CA12 (0.70) CES2CES1MEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010015652-A2 THIAZOLE COMPOUNDS AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE SMITHKLINE BEECHAM CORPORATION (US) 2010-02-11 WO disclosed
WO-2008084067-A2 PHARMACEUTICALLY ACTIVE DIHYDROBENZOFURANE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES NYCOMED GMBH (DE) 2008-07-17 WO disclosed